Company Pear Therapeutics, Inc.
Equities
PEAR
US7047231052
Biotechnology & Medical Research
Business Summary
Number of employees: 200
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | - | |
Maria Sullivan
CTO | Chief Tech/Sci/R&D Officer | - | - |
Yuri Maricich
CTO | Chief Tech/Sci/R&D Officer | 44 | - |
Ilya Gluhovsky
CTO | Chief Tech/Sci/R&D Officer | - | - |
Corey McCann
BRD | Director/Board Member | 45 | 21-11-30 |
Meara Murphy
IRC | Investor Relations Contact | - | - |
Beth Keyt
LAW | General Counsel | - | - |
Chris Valosky
SAM | Sales & Marketing | - | - |
Ellen Snow
AUD | Comptroller/Controller/Auditor | - | - |
General Counsel | 82 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 21-11-30 | |
Timothy Wicks
BRD | Director/Board Member | 58 | 22-06-13 |
Corey McCann
BRD | Director/Board Member | 45 | 21-11-30 |
Alison Bauerlein
BRD | Director/Board Member | 42 | 21-08-31 |
Shiva Rajaraman
BRD | Director/Board Member | 50 | 22-06-13 |
Paul Mango
BRD | Director/Board Member | - | 22-06-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 142,739,169 | 142,582,029 ( 99.89 %) | 0 | 99.89 % |
Company contact information
Pear Therapeutics, Inc.
200 State Street 13th Floor
02109, Boston
+
![address Pear Therapeutics, Inc.(PEAR)](https://cdn.zonebourse.com/static/address/130340629.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+16.52% | 44.87B | |
-10.59% | 37.8B | |
+40.49% | 37.61B | |
+28.72% | 31.32B | |
-9.78% | 27.4B | |
+12.30% | 26.32B | |
+41.15% | 14.07B | |
+31.95% | 12.5B | |
-7.27% | 11.23B |